Health and lifestyle

Pfizer and AstraZeneca jabs effective against Indian variant

According to health authorities’ studies in Britain published yesterday, Pfizer/Biontech and AstraZeneca/Oxford coronavirus vaccines are highly effective against the Indian variant just the way they are effective against the British variant.

According to the Public Health in England, which ran the study from April 05th to May 16th, Pfizer vaccine was found to be 88% effective at stopping symptomatic disease of the Indian variant two weeks after the second dose, compared to 93% effectiveness against the Kent variant.

AstraZeneca jab was 60% effective against the Indian variant, compared with 66% against the Kent variant.

Secretary of State for Health of the United Kingdom Matt Hancock welcomed the results of this study, as the government is counting on a national vaccination campaign to face the Indian variant, whose outbreak threatens to derail reopening plan and the country’s economy.

Following concerns on the spread of the variant first discovered in India and aiming at combating its spread, health authorizes called citizens over 50s, and those considered clinically vulnerable, to have their second dose brought forward to eight weeks after their first dose, rather than 12.

These measures were also accompanied by Covid 19 intense testing campaigns aimed in the most vulnerable areas, especially in northwest England and some parts of London.

Death toll in Britain is the largest in Europe continent, with more than 127000 deaths caused by Covid 19.

So far, 70% of adults have had a first vaccine dose, while 40% of adults have had a second jab against Coronavirus.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button